Definium Therapeutics, Inc. Common Shares (DFTX) News

Latest headlines that mention DFTX, newest first · each headline opens the original publisher

DFTX quote

Last price: $32.10
Day change: -6.30%
Next earnings: 2026-11-05

Quote & chart Expected move Insider trading IV rank history

DFTX headlines

last 30 days

Seeking Alpha News 3d ago

Definium Therapeutics: Outstanding Phase III Data De-Risks Pipeline, But Patience Required Ahead Of 2027

General T2DFTX

Investing.com 17d ago

Definium Therapeutics CMO Daniel Karlin sells $396,894 in stock

General T3DFTX

Investing.com 17d ago

Definium Therapeutics CEO Robert Barrow sells $1.15 million in shares

General T3DFTX

Investing.com 17d ago

Definium Therapeutics CLO Mark Sullivan sells $513,845 in shares

General T3DFTX

Investing.com 17d ago

Definium Therapeutics CCO Matthew Wiley sells $113,257 in common shares

General T3DFTX

Investing.com 17d ago

Definium therapeutics CFO Brandi Roberts sells $123,496 in shares

General T3DFTX

Yahoo Finance 26d ago

Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching

General T2DFTX

DFTX news alerts

Get an alert by email or push when a new headline mentions DFTX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.